Hsiao Lieu
Chief Tech/Sci/R&D Officer at NGM BIOPHARMACEUTICALS, INC.
Net worth: 55 499 $ as of 2024-03-30
Hsiao Lieu active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2019-02-28 | - |
| The University of California, San Francisco | Corporate Officer/Principal | - | - |
Career history of Hsiao Lieu
Former positions of Hsiao Lieu
| Companies | Position | Start | End |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2017-10-31 | 2019-02-28 |
| PORTOLA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2007-12-31 | 2007-12-31 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Chief Tech/Sci/R&D Officer | 2005-12-31 | 2005-12-31 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
| Retinorx LLC | Chief Executive Officer | - | - |
| Founder | - | - | |
| CAPRICOR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2008-02-29 | - |
Training of Hsiao Lieu
| New York University | Undergraduate Degree |
| Yeshiva University | Doctorate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Statistics
International
| United States | 12 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 5 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Private companies | 4 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
| Retinorx LLC | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Hsiao Lieu
- Experience
